PALUMBO, ROSALIA
PALUMBO, ROSALIA
Impact of COVID-19 outbreak on cancer patient care and treatment: Data from an outpatient oncology clinic in Lombardy (Italy)
2020-01-01 Quaquarini, E.; Saltalamacchia, G.; Presti, D.; Caldana, G.; Tibollo, V.; Malovini, A.; Palumbo, R.; Teragni, C. M.; Balletti, E.; Mollica, L.; Biscaldi, E.; Frascaroli, M.; Bernardo, A.; Sottotetti, F.
Nanoparticle albumin-bound paclitaxel (Nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: Prospective evaluation of activity, safety, and quality of life
2015-01-01 Palumbo, R.; Sottotetti, F.; Trifiro, G.; Piazza, E.; Ferzi, A.; Gambaro, A.; Spinapolice, E. G.; Pozzi, E.; Tagliaferri, B.; Teragni, C.; Bernardo, A.
Patterns of treatment and outcome of palbociclib plus endocrine therapy in hormone receptor-positive/HER2 receptor-negative metastatic breast cancer: a real-world multicentre Italian study
2021-01-01 Palumbo, R.; Torrisi, R.; Sottotetti, F.; Presti, D.; Rita Gambaro, A.; Collova, E.; Ferzi, A.; Agostinetto, E.; Maria Teragni, C.; Saltalamacchia, G.; Tagliaferri, B.; Balletti, E.; Bernardo, A.; Quaquarini, E.
Patterns of treatment and outcome with 500-mg fulvestrant in postmenopausal women with hormone receptor-positive/HER2-negative metastatic breast cancer: a real-life multicenter Italian experience
2019-01-01 Palumbo, R.; Sottotetti, F.; Quaquarini, E.; Gambaro, A.; Ferzi, A.; Tagliaferri, B.; Teragni, C.; Licata, L.; Serra, F.; Lapidari, P.; Bernardo, A.
Prognostic Value of 18 F-Fluorocholine PET Parameters in Metastatic Castrate-Resistant Prostate Cancer Patients Treated with Docetaxel
2019-01-01 Quaquarini, Erica; D'Ambrosio, D.; Sottotetti, Federico; Gallivanone, F.; Hodolic, M.; Baiardi, P.; Palumbo, Rosalia; Vellani, C.; Canevari, C.; Bernardo, A.; Castiglioni, I.; Porta, C.; Trifiro, G.
Role of androgen receptor expression in early stage ER+/PgR−/HER2– breast cancer
2020-01-01 Tagliaferri, B.; Quaquarini, E.; Palumbo, R.; Balletti, E.; Presti, D.; Malovini, A.; Agozzino, M.; Teragni, C. M.; Terzoni, A.; Bernardo, A.; Villani, L.; Sottotetti, F.
Targeted chemotherapy with nanoparticle albumin-bound paclitaxel (nab -paclitaxel) in metastatic breast cancer: Which benefit for which patients?
2016-01-01 Palumbo, R.; Sottotetti, F.; Bernardo, A.
Uncommon dihydropyrimidine dehydrogenase mutations and toxicity by fluoropyrimidines: A lethal case with a new variant
2016-01-01 Del Re, M.; Quaquarini, E.; Sottotetti, F.; Michelucci, A.; Palumbo, R.; Simi, P.; Danesi, R.; Bernardo, A.
Vinflunine in Advanced Transitional Cell Cancer of the Urothelial Tract: A Potential Option for Maintenance Therapy? A Case Series
2018-01-01 Palumbo, R.; Licata, L.; Sottotetti, F.; Tagliaferri, B.; Pozzi, E.; Teragni, C.; Quaquarini, E.; Bernardo, A.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Impact of COVID-19 outbreak on cancer patient care and treatment: Data from an outpatient oncology clinic in Lombardy (Italy) | 1-gen-2020 | Quaquarini, E.; Saltalamacchia, G.; Presti, D.; Caldana, G.; Tibollo, V.; Malovini, A.; Palumbo, R.; Teragni, C. M.; Balletti, E.; Mollica, L.; Biscaldi, E.; Frascaroli, M.; Bernardo, A.; Sottotetti, F. | |
| Nanoparticle albumin-bound paclitaxel (Nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: Prospective evaluation of activity, safety, and quality of life | 1-gen-2015 | Palumbo, R.; Sottotetti, F.; Trifiro, G.; Piazza, E.; Ferzi, A.; Gambaro, A.; Spinapolice, E. G.; Pozzi, E.; Tagliaferri, B.; Teragni, C.; Bernardo, A. | |
| Patterns of treatment and outcome of palbociclib plus endocrine therapy in hormone receptor-positive/HER2 receptor-negative metastatic breast cancer: a real-world multicentre Italian study | 1-gen-2021 | Palumbo, R.; Torrisi, R.; Sottotetti, F.; Presti, D.; Rita Gambaro, A.; Collova, E.; Ferzi, A.; Agostinetto, E.; Maria Teragni, C.; Saltalamacchia, G.; Tagliaferri, B.; Balletti, E.; Bernardo, A.; Quaquarini, E. | |
| Patterns of treatment and outcome with 500-mg fulvestrant in postmenopausal women with hormone receptor-positive/HER2-negative metastatic breast cancer: a real-life multicenter Italian experience | 1-gen-2019 | Palumbo, R.; Sottotetti, F.; Quaquarini, E.; Gambaro, A.; Ferzi, A.; Tagliaferri, B.; Teragni, C.; Licata, L.; Serra, F.; Lapidari, P.; Bernardo, A. | |
| Prognostic Value of 18 F-Fluorocholine PET Parameters in Metastatic Castrate-Resistant Prostate Cancer Patients Treated with Docetaxel | 1-gen-2019 | Quaquarini, Erica; D'Ambrosio, D.; Sottotetti, Federico; Gallivanone, F.; Hodolic, M.; Baiardi, P.; Palumbo, Rosalia; Vellani, C.; Canevari, C.; Bernardo, A.; Castiglioni, I.; Porta, C.; Trifiro, G. | |
| Role of androgen receptor expression in early stage ER+/PgR−/HER2– breast cancer | 1-gen-2020 | Tagliaferri, B.; Quaquarini, E.; Palumbo, R.; Balletti, E.; Presti, D.; Malovini, A.; Agozzino, M.; Teragni, C. M.; Terzoni, A.; Bernardo, A.; Villani, L.; Sottotetti, F. | |
| Targeted chemotherapy with nanoparticle albumin-bound paclitaxel (nab -paclitaxel) in metastatic breast cancer: Which benefit for which patients? | 1-gen-2016 | Palumbo, R.; Sottotetti, F.; Bernardo, A. | |
| Uncommon dihydropyrimidine dehydrogenase mutations and toxicity by fluoropyrimidines: A lethal case with a new variant | 1-gen-2016 | Del Re, M.; Quaquarini, E.; Sottotetti, F.; Michelucci, A.; Palumbo, R.; Simi, P.; Danesi, R.; Bernardo, A. | |
| Vinflunine in Advanced Transitional Cell Cancer of the Urothelial Tract: A Potential Option for Maintenance Therapy? A Case Series | 1-gen-2018 | Palumbo, R.; Licata, L.; Sottotetti, F.; Tagliaferri, B.; Pozzi, E.; Teragni, C.; Quaquarini, E.; Bernardo, A. |